There are a number of less penetrant mutations associated with melanoma proliferation: NRAS mutation is the next most common cause of aberrant signaling within the MAPK pathway and may be responsible for as many as 30% of somatic mutations affecting the MAPK cascade [107]. This evidence concerns the gene NRAS and melanoma.